Strides Shasun Q2 net profit rises over two-fold to Rs 74cr
New Delhi : Drug firm Strides Shasun reported over two-fold jump in consolidated net profit to Rs 74.09 crore during the second quarter ended September 30, on account of higher sales.
The company had posted a net profit of Rs 35.81 crore for the corresponding period of previous fiscal.
The company's total income from operations went up by 33.34 per cent to Rs 953.47 crore during the quarter under review compared to Rs 715.06 crore in the year-ago period, Strides Shasun said in a BSE filing.
"The regulated markets and the institutional business continue to deliver healthy growth with an improved sequential performance on a higher revenue base Active pharmaceutical ingredients (API) performance during the quarter was impacted," Strides Shasun Executive Vice Chairman and Managing Director Arun Kumar said.
Shares of Strides Shasun were trading 8.19 per cent higher at Rs 1,016.77 on BSE.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd